The hormone replacement therapy taken by millions of women to relieve hot flashes and other symptoms of menopause may raise the risk of dying from lung cancer. New findings from the landmark Women’s Health Initiative study show that women with non-small cell lung cancer are 59% more likely to die from the disease if they take combined estrogen and progestin.
The Secret History of the War on Cancer By Devra Davis, PhD, MPH Review by Leslie Botha, Holy Hormones Honey! In a recent interview on CSPAN Davis stated, “For much of its history, the cancer war has been fighting the wrong battles, with the wrong weapons, against the wrong enemies.” The Secret History of the [...]
…and may limit effectiveness of these breast cancer detection methods Women who take combined hormone therapy for about five years have a higher risk of abnormal mammograms and breast biopsies. This, in turn, may decrease the effectiveness of these methods of detecting breast cancer, according to a new study published in the Feb. 25 issue [...]
…3 Years Later Increased risk for adverse cardiovascular outcomes and invasive breast cancer — and reduced risk for fractures and colorectal cancer — did not persist after women discontinued HT. In the summer of 2002, the Women’s Health Initiative (WHI) randomized trial of estrogen plus progestin was stopped after the WHI writing group concluded that [...]
Main Outcome: Measures Semi-annual monitoring and outcomes ascertainment continued per trial protocol. The primary end points were coronary heart disease and invasive breast cancer. A global index summarizing the balance of risks and benefits included the 2 primary end points plus stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip fracture, and death due to other causes.
The Women’s Health Initiative (WHI) Trial Team Gerardo Heiss, MD; Robert Wallace, MD; Garnet L. Anderson, PhD; Aaron Aragaki, MS; Shirley A. A. Beresford, PhD; Robert Brzyski, MD; Rowan T. Chlebowski, MD; Margery Gass, MD; Andrea LaCroix, PhD; JoAnn E. Manson, MD; Ross L. Prentice, PhD; Jacques Rossouw, MD; Marcia L. Stefanick, PhD; for the [...]
When I first read this report, I was reminded of that classic 50′s cigarette commercial that featured a lab-cloaked “DOCTOR” (Queue Heavenly Chorus) and asked, ”What cigarette do you smoke, Doctor?” Hey if a Camel® is good enough Doctors, surely cigarette smoke is safe? Right! Who would question a doctor back in the golden days [...]
The latest in a series of health scares associated with Hormone Replacement Therapy Women on hormone replacement therapy have a 20 per cent higher risk of dying from ovarian cancer, says a new report. The research, from the authoritative Million Women study, suggests that as many as 1,000 women may have died from ovarian cancer [...]
“Pill Pimp” Market Strategy Targets Women At Every Stage Of Life Once again, Leslie Botha has been proven to be an accurate soothsayer. In her radio program, on her website and in her seminars, Leslie has pointed out that, Big Pharma is mirroring the successful marketing strategies of the American Cigarette Industry — lure the [...]
Nothing Changes, Unless SOMETHING Changes I first read this report in late 2003. I feel the information is still relevant, particularly with the media-marketing buzz around the ‘convenience of menstrual suppression’ becoming more pervasive. In one of her more cynical moments, my writing partner, Leslie Botha , stated, well since the Post-menopausal ’Wise Women’ have [...]
© 2002- An Inconvenient Woman. Site design and construction by Pleiades Publishing Services, Co.
Powered by Wordpress and based on the template design MyJournal Hypereal by 
BlogoSquare
